Endologix (ELGX) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
Go back to Endologix (ELGX) Tops Q3 EPS by 1c
October 26, 2015 4:03 PM EDT
Nellix European Systems Increase 45% Over Prior Year
FDA Approves Additional Patient Enrollment in Nellix U.S. CAP
IRVINE, Calif., Oct. 26, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ: ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2015.
John McDermott, Endologix Chairman and Chief Executive Officer, said, "We achieved solid third quarter results, highlighted by a 45% increase in European Nellix® system sales. We are also pleased with FDA... More
October 26, 2015 4:02 PM EDT
Combined Product Portfolio to Provide Clinicians With a Broad Range of Endovascular AAA Devices
Will Expand U.S. and European Sales Organizations to Enhance Growth and Provide Excellent Clinical Support
Endologix to Host Conference Call Today at 5:00 p.m. ET
IRVINE, Calif., and SANTA ROSA, Calif., Oct. 26, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq: ELGX) and TriVascular Technologies, Inc. (Nasdaq: TRIV) announced today that they have entered into a definitive merger agreement under which... More
